Gilead Sciences Limited

Information

Name

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

http://www.gilead.com

Address

London

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Gilead Sciences Limited
Sign up free

Contracts awarded to Gilead Sciences Limited

The contracts that Gilead Sciences Limited have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 2 weeks ago

SOFOSBUVIR 400mg / VELPATASVIR 100mg Tablets 28 Tablet Pack

Procurement of SOFOSBUVIR 400mg / VELPATASVIR 100mg Tablets 28 Tablet Pack

£320,000
Award

Published 1 month ago

NHS National Framework for Transition products commencing 1 October 2024

Project title: NHS National Framework for Transition products commencing 1 October 2024 Offer reference number: CM/TNS/24/5712 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) CM/TNS/24/5712/02 - Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

£41,320,000 Bids close: 3 months ago
Award

Published 1 month ago

NHS National Framework for Transition products commencing 1 October 2024

Project title: NHS National Framework for Transition products commencing 1 October 2024 Offer reference number: CM/TNS/24/5712 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) CM/TNS/24/5712/02 - Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

£13
Award

Published 9 months ago

REMDESIVIR

Procurement of REMDESIVIR

£700,000

Gilead Sciences Limited

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Gilead Sciences Limited

SOFOSBUVIR 400mg / VELPATASVIR 100mg Tablets 28 Tablet Pack

NHS National Framework for Transition products commencing 1 October 2024

NHS National Framework for Transition products commencing 1 October 2024

REMDESIVIR

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win